News

Diplomat Specialty Pharmacy earns spot on 2012 Inc. 5000

BY Allison Cerra

FLINT, Mich. — Diplomat Specialty Pharmacy has earned a spot on Inc. magazine’s annual ranking of the fastest-growing private companies in America.

Honored for the fourth consecutive year, the specialty pharmacy provider ranked No. 1 when combing revenue and growth rate of 2012 Inc. 5000 companies operating in the health industry, ranked No. 4 in total revenue of 2012 Inc. 5000 companies operating in the health industry and generated more than $502 million in growth over three years.

"We’re proud to be recognized by Inc. again this year, earning a position of 1585 in the nation, but if you dig a little deeper into Inc.’s numbers, the details are even more remarkable," Diplomat CEO Phil Hagerman said. "Despite our unprecedented growth over the years, we’ve continued to stay dedicated to our patient focused model and achieved a 98% customer satisfaction response from our 2012 patient satisfaction survey. We could not achieve this without a tremendous staff committed to finding solutions for both patients and our healthcare partners."


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Genzyme provides update on Lemtrada filing with FDA

BY Allison Cerra

CAMBRIDGE, Mass. — Genzyme announced it has received a refuse-to-file letter from the Food and Drug Administration in response to the drug maker’s supplemental biologics license application for the approval of Lemtrada (alemtuzumab) as a treatment for relapsing multiple sclerosis.

The agency requested that the company modify the presentation of the data sets to enable the agency to better navigate the application. The FDA has not requested additional data or further studies. Genzyme will work with the FDA over the coming weeks to resubmit the application as soon as possible, the drug maker said.

"We have had constructive dialogue with the FDA, and we are very confident in our ability to address the agency’s request and resubmit rapidly," Genzyme president and CEO David Meeker said.

Genzyme is developing Lemtrada in MS in collaboration with Bayer HealthCare.


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Multichannel strategies rise in importance

BY Antoinette Alexander

WHAT IT MEANS AND WHY IT’S IMPORTANT — Do you doubt the importance of having a multichannel strategy to reach shoppers? If so, consider the fact that — for as little 2.5% off — nearly half of your customers will walk out of the store to make their purchase online. How about a 5% discount? Well, that number jumps to 60% of shoppers who will leave.

(THE NEWS: Study: Discounts as low as 2.5% sway shoppers to leave stores, purchase online. For the full story, click here)

That’s according to recent showrooming research from GroupM Next and, as many would likely agree, that’s a pretty darn compelling reason to implement a multichannel strategy.

That’s not the only study that stresses the importance of such a strategy. A recent report from IBM noted a rise in mobile shopping and a dip in social media sales during the second quarter — further evidence supporting the importance of a multichannel approach.

“Shoppers today are shifting from a singular online approach to a multichannel experience that includes both mobile and social media,” Craig Hayman, GM at IBM Industry Solutions, had stated in announcing the study results. “As a result, retailers must be prepared to connect with their customers on all fronts, or lose them to the competition. As we enter the home stretch for the 2012 holiday season, we will continue to watch how CMOs and CIOs tackle these challenges and create social media efforts that deliver value to the customer while driving revenue for the business."

Several retailers are, in fact, heeding the call. For example, earlier this year, Walgreens announced that it would publish a digital edition of its weekly advertising circular offering additional items through Walgreens.com and the company’s mobile applications as a way to complement its “multichannel strategy by finding new and different ways to cater to today’s consumers.”

Clearly, there is mounting evidence that having a multichannel strategy is key, and those retailers that want to effectively reach today’s shoppers are wise not to rest on their laurels.

What do you think is the most effective multichannel strategy for today’s retailers and suppliers?

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?